Monashee Investment Management LLC Compass Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

$730 Million
Q1 2025

A detailed history of Monashee Investment Management LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Monashee Investment Management LLC holds 448,164 shares of CMPX stock, worth $1.12 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

448,164

Previous 448,164 -0.0%

Holding current value

$1.12 Million

Previous $649,000 31.12%

% of portfolio

0.12%

Previous 0.1%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.35 - $1.98 $69,978 - $102,635	-51,836 Reduced 10.37%	448,164 $649,000
Q4 2023 Feb 12, 2024	SELL	$1.4 - $1.98 $1.02 Million - $1.44 Million	-726,142 Reduced 59.22%	500,000 $780,000
Q3 2023 Nov 13, 2023	SELL	$1.87 - $3.25 $1.39 Million - $2.42 Million	-743,154 Reduced 37.74%	1,226,142 $2.42 Million
Q2 2023 Aug 10, 2023	SELL	$2.64 - $3.48 $548,449 - $722,956	-207,746 Reduced 9.54%	1,969,296 $6.26 Million
Q1 2023 May 05, 2023	SELL	$3.14 - $5.48 $167,672 - $292,626	-53,399 Reduced 2.39%	2,177,042 $7.12 Million
Q4 2022 Feb 09, 2023	BUY	$2.55 - $5.41 $2.55 Million - $5.41 Million	1,000,000 Added 81.27%	2,230,441 $11.2 Million
Q2 2022 Aug 12, 2022	SELL	$1.43 - $3.1 $56,871 - $123,287	-39,770 Reduced 3.13%	1,230,441 $3.26 Million
Q1 2022 May 12, 2022	SELL	$1.25 - $3.5 $912,236 - $2.55 Million	-729,789 Reduced 36.49%	1,270,211 $1.74 Million
Q4 2021 Feb 07, 2022	BUY	$2.88 - $3.98 $5.76 Million - $7.96 Million	2,000,000 New	2,000,000 $6.34 Million

Others Institutions Holding CMPX

# of Institutions

127

Shares Held

101M

Call Options Held

2.52M

Put Options Held

3.1M

View Full List

About Compass Therapeutics, Inc.

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $254M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

More about CMPX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Account

Monashee Investment Management LLC Compass Therapeutics, Inc. Transaction History